Association between reproductive history, breast cancer subtype, and survival in premenopausal women

Reproductive history influences breast cancer risk. We analysed its association with tumour subtype and survival in premenopausal women. Retrospective, observational study of premenopausal women with stage I-III breast carcinoma in the last 20 years. Review of reproductive history, clinical data, an...

Full description

Saved in:
Bibliographic Details
Published inMedicina clinica Vol. 162; no. 6; p. 265
Main Authors Bernal-Gómez, Marta, Núñez-Álvarez, Violeta, Lluch-Gómez, Jaime, de la Torre-Hita, Carlos, Campini-Bermejo, Alicia, Perdomo-Zaldívar, Eduardo, Rodríguez-Pérez, Lourdes, Calvete-Candenas, Julio, Benítez-Rodríguez, Encarnación, Baena-Cañada, José Manuel
Format Journal Article
LanguageEnglish
Spanish
Published Spain 22.03.2024
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:Reproductive history influences breast cancer risk. We analysed its association with tumour subtype and survival in premenopausal women. Retrospective, observational study of premenopausal women with stage I-III breast carcinoma in the last 20 years. Review of reproductive history, clinical data, and treatments in health records. In 661 premenopausal women (32.40% of 1377 total cases), median age was 47 years (19-53), menarche 12 (7-17), first delivery 28 (16-41) and number of deliveries 2 (0-9). One hundred and eleven (18.20%) were nulliparous. Three hundred and fifty-nine (58.80%) used natural lactation, with a median duration of 6 months. Anovulatory drugs were used by 271 (44.40%), with a median duration of 36 months. Associations were found between menarche <10 years and lower risk of luminal subtype (OR: 0.52, 95% CI: 0.28-0.94; P=.03), between menarche >11 years and lower risk of HER2 subtype (OR: 0.50, 95% CI: 0.26-0.97; P=.04) and between first birth >30 years and lower risk of triple negative subtype (OR: 0.40, 95% CI: 0.17-0.93; P=.03). The 20-year overall and disease-free survival probabilities were 0.80 (95% CI: 0.71-0.90) and 0.72 (95% CI: 0.64-0.79) respectively. Patients with ≥1 delivery had better overall survival than nulliparous patients (HR: 0.51, 95% CI: 0.27-0.96, P=.04). The findings suggest an association between age at menarche and age at first delivery and breast cancer subtype. Nulliparity is associated with worse survival.
ISSN:1578-8989
DOI:10.1016/j.medcli.2023.10.015